-
Conflicts of interest reported for FDA panel that signed off on Yaz birth control drug
Wednesday, January 11, 2012 � by jg
Washington Monthly blog: An investigation by journalists found some members of a U.S. Food and Drug Administration committee of medical experts that looked into the potential dangers of the Bayer birth control pills Yaz and Yasmin had potential conflicts of interest.
-
Former FDA head says Bayer withheld data about Yasmin
Monday, December 5, 2011 � by jg
Bloomberg: David Kessler says in court documents that the pharmaceutical giant withheld information that users of the company’s Yasmin birth control pills had increased reports of blood clots.
-
Drugmaker agrees to pay more than $1 billion in Paxil settlements
Wednesday, July 28, 2010 � by jg
Bloomberg BusinessWeek: GlaxoSmithKline’s latest agreement involves more than 800 birth defect cases and brings the total it has agreed to pay in Paxil-related settlements to more than $2 billion.
-
Jury awards $8 million in Fosamax case
Monday, June 28, 2010 � by jg
Associated Press: A 72-year-old woman has been awarded $8 million in compensatory damages after a jury ruled Fosamax is “unreasonably dangerous due to defective design.”
-
Maker of Paxil agrees to settle suits brought over birth defects
Wednesday, June 23, 2010 � by jg
The Legal Intelligencer: GlaxoSmithKline “has agreed to settle almost 200 cases in which plaintiffs allege the use of the antidepressant caused birth defects.”
-
California’s Tort Wars: Election Day by the numbers
Friday, June 11, 2010 � by eric
Tort-war front groups for big oil, insurance and tobacco get walloped on election day.
-
Congressional committee chair says he hasn’t gotten a “straight story” from J&J
Friday, June 11, 2010 � by jg
New York Times: Edolphus Towns said Johnson & Johnson has held up an investigation his committee has undertaken into the company’s recent pediatric drug recalls.